In 2025, Sabiedrība ar ierobežotu atbildību "CentralPharma Communications" had revenue of 268.9 thousand EUR and profit of 166 EUR. The company has 5 employees. Beneficial owners: Kadri Kaend.
| year | 2025Latest | 2024 | 2023 |
|---|---|---|---|
Revenue | 268,9k € -9.0% | 295,4k € +35.6% | 217,8k € +31.9% |
Profit | 166 € -36.4% | 261 € +68.4% | 155 € -70.7% |
Assets | 60,4k € +5.3% | 57,4k € +1.5% | 56,6k € +16.9% |
Liabilities | 26,4k € +12.1% | 23,6k € +2.5% | 23k € +53.7% |
Equity | 34k € +0.5% | 33,8k € +0.8% | 33,6k € +0.5% |
Employees | 5 +0.0% | 5 +0.0% | 5 +25.0% |
Overall rating | A87/100 |
Financial health | 85/100 |
Credit history | 100/100 |
Legal history | 100/100 |
Business activity | 50/100 |
| Overall risk | Low |
No risk flags | |
No tax debts | |
Positive profit | |
Regular report filing | |
| Name, surname | Birth date | Position | Representation rights | Registered | |
|---|---|---|---|---|---|
| - | Board member | Independently |
| Name | Changed |
|---|---|
| Sabiedrība ar ierobežotu atbildību "CENTRALPHARMA COMMUNICATIONS" | 11 February 2005 |
| Sabiedrība ar ierobežotu atbildību "CENTRALPHARMA COMMUNICATIONS" | 11 February 2005 |
| Sabiedrība ar ierobežotu atbildību "CENTRALPHARMA COMMUNICATIONS" | 11 February 2005 |
| Sabiedrība ar ierobežotu atbildību "CENTRALPHARMA COMMUNICATIONS" | 11 February 2005 |
| Sabiedrība ar ierobežotu atbildību "CENTRALPHARMA COMMUNICATIONS" | 11 February 2005 |
| Sabiedrība ar ierobežotu atbildību "CENTRALPHARMA COMMUNICATIONS" | 11 February 2005 |
| Sabiedrība ar ierobežotu atbildību "CENTRALPHARMA COMMUNICATIONS" | 11 February 2005 |
| Sabiedrība ar ierobežotu atbildību "CENTRALPHARMA COMMUNICATIONS" | 11 February 2005 |
| Sabiedrība ar ierobežotu atbildību "CENTRALPHARMA COMMUNICATIONS" | 11 February 2005 |
| Sabiedrība ar ierobežotu atbildību "CENTRALPHARMA COMMUNICATIONS" | 11 February 2005 |
| Sabiedrība ar ierobežotu atbildību "CENTRALPHARMA COMMUNICATIONS" | 11 February 2005 |
| Sabiedrība ar ierobežotu atbildību "CENTRALPHARMA COMMUNICATIONS" | 11 February 2005 |
| Sabiedrība ar ierobežotu atbildību "CENTRALPHARMA COMMUNICATIONS" | 11 February 2005 |
| Sabiedrība ar ierobežotu atbildību "CENTRALPHARMA COMMUNICATIONS" | 11 February 2005 |
| Sabiedrība ar ierobežotu atbildību "CENTRALPHARMA COMMUNICATIONS" | 11 February 2005 |
| Sabiedrība ar ierobežotu atbildību "CENTRALPHARMA COMMUNICATIONS" | 11 February 2005 |
| Sabiedrība ar ierobežotu atbildību "CENTRALPHARMA COMMUNICATIONS" | 11 February 2005 |
| Sabiedrība ar ierobežotu atbildību "CENTRALPHARMA COMMUNICATIONS" | 11 February 2005 |
| Sabiedrība ar ierobežotu atbildību "CENTRALPHARMA COMMUNICATIONS" | 11 February 2005 |
| Sabiedrība ar ierobežotu atbildību "CENTRALPHARMA COMMUNICATIONS" | 11 February 2005 |
Sabiedrība ar ierobežotu atbildību "CentralPharma Communications" is located at Rīga, Baložu iela 28 - 13, LV-1048.
In 2025, Sabiedrība ar ierobežotu atbildību "CentralPharma Communications" had revenue of 268 900 EUR and profit of 166 EUR. Compared to previous year, revenue decreased by 9.0%. View full financial report →
In 2024, Sabiedrība ar ierobežotu atbildību "CentralPharma Communications" had an average of 5 employees. View tax history →
The beneficial owners of Sabiedrība ar ierobežotu atbildību "CentralPharma Communications" are Kadri Kaend. View ownership details →
Yes, Sabiedrība ar ierobežotu atbildību "CentralPharma Communications" is registered as an active VAT payer with VAT number LV40003521795.
In 2024, the average gross salary at Sabiedrība ar ierobežotu atbildību "CentralPharma Communications" was approximately 3396,89 € per month (net ~ 2395,01 €). This is an approximate calculation. View salary details →
Sabiedrība ar ierobežotu atbildību "CentralPharma Communications" was founded on December 6, 2000. The company has been operating for 26 years.
| Indicator | Value | Rank | Comparison | |
|---|---|---|---|---|
Company age | 26 years | - | 0% | |
Net revenue | 268 900,00 € | - | 0% | |
Profit | 166,00 € | - | 0% | |
Equity | 33 998,00 € | - | 0% | |
Assets | 60 431,00 € | - | 0% | |
Liquidity | 2.29 | - | 75% | |
Profitability | 0.1% | - | 10% | |
Registered capital | 2828,00 € | - | 0% |
Annual financial report for 2025.
Annual financial report for 2024.
Annual financial report for 2023.
Annual financial report for 2022.
Annual financial report for 2021.
Annual financial report for 2020.
Registered in the Latvian company register.
| Name, surname | Shares | Ownership rights |
|---|---|---|
| OU CentralPharma Communications | 101 | 100.00% |
| Name, surname | Nationality | Birth date | |
|---|---|---|---|
| Kadri Kaend | EE | - |